Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet function in essential thrombocythemia with anagrelide or hydroxyurea
NL-OMON35998Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of anagrelide and hydroxyurea in thrombocythemia, sponsored by University Medical Center Utrecht. Primary endpoint: Platelet reactivity under static conditions. Started Nov 2012; status: active, not recruiting.
02
Drugs
anagrelidehydroxyurea
03
Conditions
thrombocythemia
Beyond the preview
Go deeper on NL-OMON35998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35998.